Devika Das, MD, MSHQS, FASCO

@DevikaDasMD

Thoracic Medical Oncologist, QI and safety Leader, Medical Educator 🛑 Updates coming soon! 🛑

Gainesville,FL

Joined October 2017

3KFollowing

6KFollowers

Pinned

Devika Das, MD, MSHQS, FASCO@DevikaDasMD · Jun 24

Honored to announce that I’ve accepted the role of Division Director of Hem/Onc and Associate Director for Clinical Affairs at the Cancer Center, University of Mississippi! Looking forward to contributing to the team’s growth and success this fall! #lcsm @UMMC_Cancer @rodrocconi

250

20.0K

Devika Das, MD, MSHQS, FASCO@DevikaDasMD · Jul 25

Been seeing it in my practice quite often. Excellent review! #lcsm #oncMedEd

EESMO Open@ESMO_Open · Jul 24

Efficacy of first-line treatments for advanced pulmonary sarcomatoid carcinomas: a real-world analysis in @ESMO_Open. 229 pts, 169 treated with 1st line Tx, 68.6% PD-L1 high, 39.7% KRAS mut. Longer PFS and OS with ICIs+/-CT as compared to CT alone. esmoopen.com/article/S2059-…

469

Devika Das, MD, MSHQS, FASCO@DevikaDasMD · Jul 25

Thanks @chadinabhan for this wonderful opportunity. Hope this is helpful for our incoming and Senior fellows. @IMG_Oncologists @Noha_Soror @NazliDizman @OncoThor @TheFellowOnCall @ASCO @PallOncCoP @OncMedEdCoP @MayoHemeOnc @MayoCancerCare @MayoClinic @MayoRadOnc @MayoMedEd…

cchadi nabhan MD, MBA, FACP@chadinabhan · Jul 25

This last weekend in July, spend some time W @JasmineKambojMD on #HUExpress advising Hem/Onc fellows starting training this month. "How to Survive & Thrive in fellowship?" @HemOncFellows @TheFellowOnCall @IMG_Oncologists @ASCO @Noha_Soror @marklewismd @docbraunstein @VincentRK

1.0K

Devika Das, MD, MSHQS, FASCO@DevikaDasMD · Jul 25

Yes! That’s what we have been doing but realized that there is very awareness on this topic within the oncology community! Both in SOC and clinical trials #oncmeded @HemOncFellows #lcsm

BBijoy Telivala@BijoyTelivala · Jul 25

Time to check Cystatin C Bactrim also can cause false rise in creat due to Trimethoprim

450

Devika Das, MD, MSHQS, FASCO@DevikaDasMD · Jul 25

Several TKIs can inhibit OCT2 and MATE1, leading to elevated serum creatinine levels without affecting the GFR, a phenomenon known as pseudo-acute kidney injury. Sharing our correspondence regarding the same @JCO_ASCO #oncmeded #lcsm ascopubs.org/doi/10.1200/JC…

DevikaDasMD's tweet image. Several TKIs can inhibit OCT2 and MATE1, leading to elevated serum creatinine levels without affecting the GFR, a phenomenon known as pseudo-acute kidney injury. Sharing our correspondence regarding the same @JCO_ASCO #oncmeded #lcsm

ascopubs.org/doi/10.1200/JC…

3.0K

Devika Das, MD, MSHQS, FASCO Retweeted

Cancer Today@CancerTodayMag · Jul 21

Ever been confused by your insurance company's prior authorization process? You're not alone. We asked @AshleySumrallMD to explain what patients and caregivers should know about prior authorization: brnw.ch/21wUjvi

840

Devika Das, MD, MSHQS, FASCO Retweeted

Oscar Tahuahua@OscarTahuahua · Jul 23

Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy. @NEJM 2025 Tarlatamab, a DLL3-targeted BiTE, showed mOS of 14.3 mo in SCLC post 1L chemo +/- ICI, offering benefit in this aggressive, hard to treat setting www-nejm-org.wdg.biblio.udg.mx:8443/doi/full/10.10…

5.0K

Devika Das, MD, MSHQS, FASCO Retweeted

ESMO Open@ESMO_Open · Jul 22

Treatment outcome of NSCLC patients with BRAFnon-V600Emutations: a retrospective, multicentre analysis within the nNGM Lung Cancer in Germany in @ESMO_Open. Different results with targeted therapies by mutation type even among non-V600E NSCLC. esmoopen.com/article/S2059-…

4.0K

Devika Das, MD, MSHQS, FASCO Retweeted

UMMC Cancer Center and Research Institute@UMMC_Cancer · Jul 22

Physicians, researchers and clinical staff from the Cancer Center and Research Institute made a big impact at the recent Gulf Coast Hematology & Oncology Summit. We’re proud of our team for leading the way in cancer research and care across the Gulf Coast! @rodrocconi

849

Devika Das, MD, MSHQS, FASCO@DevikaDasMD · Jul 21

So glad we got to work together and looking forward to many more collaborations soon! 💖@HemOncWomenDocs and UF is lucky to have you taking charge to advance the mission of #lcsm care in Florida!

AAline Fares@AlineFaresMD · Jul 21

Though I had the chance to work w Dr. Das for only a few months at UF, I learned so much from her dedication, leadership,passion for lung cancer care. Wishing her all the best as she takes on a new role as Head of MedOnc - next team is lucky to have her! Will miss u @DevikaDasMD

581

Devika Das, MD, MSHQS, FASCO@DevikaDasMD · Jul 21

What a terrific list of folks including so many members of the GU family - @WalterStadler5 @cityofhope, @umangtalking @huntsmancancer, @TiansterZhang @utswcancer, @apolo_andrea @theNCI & so many other friends! @YJanjigianMD @DevikaDasMD @ErikaHamilton9

AASCO@ASCO · Jul 21

Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO. Learn more about FASCO distinction: brnw.ch/21wUiVu

5.0K

Devika Das, MD, MSHQS, FASCO@DevikaDasMD · Jul 21

Thank you to @ASCO for the FASCO designation! I appreciate the opportunities to contribute over the years through collaboration, advocacy, and volunteer work. 🎉Congratulations to the other designees as well! 🎉 #Lcsm #WomeninMedicine @HemOncWomenDocs

AASCO@ASCO · Jul 21

3.0K

Devika Das, MD, MSHQS, FASCO Retweeted

Supriya peshin@supriyadocc · Jul 19

It feels truly surreal to be entering this hematology-oncology fellowship application cycle, pursuing my passion for GIOncology. My interests focus on GI cancers, early-onset malignancies, and healthcare disparities, with a special focus on clinical trials. Grateful to all my…

15.0K

Devika Das, MD, MSHQS, FASCO Retweeted

Avi Harisingani, MD@AviHarisingani · Jul 17

Excited to have submitted my Heme/Onc 🩸fellowship application! Would not have been possible without my mentors, and my Fiancé (future 🫁) @97nikitagupta! AAMC ID: 15136839 Especially grateful for the support from @Nischistocyte @LoyolaOnc @MacNealIMRP! Looking forward to what…

6.0K

Devika Das, MD, MSHQS, FASCO@DevikaDasMD · Jul 15

Huge kudos to our interns at UF for completing their first block on the inpatient oncology service which is a tough place to start, but they showed incredible compassion, excellence and resilience. Wishing them all the best as they continue their journey! 💪 #MedTwitter #OncMedEd

DevikaDasMD's tweet image. Huge kudos to our interns at UF for completing their first block on the inpatient oncology service which is a tough place to start, but they showed incredible compassion, excellence and resilience. Wishing them all the best as they continue their journey! 💪 #MedTwitter #OncMedEd

2.0K

Devika Das, MD, MSHQS, FASCO Retweeted

Dr. Justin Turner@DrJustinMTurner · Jul 8

I’m coming home again! I was honored to be selected in the inaugural class of HEALing Fellows by then Vice Chancellor Dr James Keeton in 2011 as a resident physician @UMMCnews . @MeharryMedical had trained me well to ALWAYS be a voice for the voiceless and to advocate for…

3.0K

Devika Das, MD, MSHQS, FASCO Retweeted

Diego A. Díaz García@diegoadiazg · Jul 5

🫁 Subclonal immune evasion in NSCLC: Using organoid–T cell co-cultures from TRACERx, researchers show genetically distinct tumor subclones can evade immunity differently, even within the same tumor. Immune escape isn’t uniform, it’s evolutionary and clonal. 📖 @Cancer_Cell 👉…

3.0K

Devika Das, MD, MSHQS, FASCO Retweeted

UAB Cardiovascular Disease@UABCardiology · Jul 2

We are deeply saddened by the recent loss of Dr. Elopre, she was a beloved physician and advocate at UAB. Please consider supporting this GoFundMe to help secure her children's educational future. 🔗gofund.me/c322f43f

1.0K

Devika Das, MD, MSHQS, FASCO Retweeted

Oncology Brothers@OncBrothers · Jul 2

Sunvozertinib (oral EGFR inhibitor, 200mg Qd) now @US_FDA approved based off PhII WU-KONG1 in previously treated Exon20ins mNSCLC: - Confirmed 44.9% ORR w/ 9mos DoR: 57% - ≥Gr 3: Diarrhea (17%), CPK levels (11%), and anemia (3.6%) #OncTwitter #MedTwitter

13.0K

Devika Das, MD, MSHQS, FASCO@DevikaDasMD · Jul 1

July 1st marks exciting new beginnings in medicine! To new trainees: even on the toughest days, treat others as you’d want yourself or your loved ones cared for—you’ll never go wrong. Wishing you all the best! #MedEd #OncMedEd 🎉

545

Devika Das, MD, MSHQS, FASCO Retweeted

ASPIRE Community of Practice@ASPIRE_CoP · Jun 27

🧠 Stay sharp with the latest in #irAE research! From duplilumab in cutaneous toxicities to survival outcomes with inpatient ICI use—check out our curated #ASPIRE reading list 🔥. Start reading now in our latest newsletter: mailchi.mp/325da8534919/f… #Immunotherapy #irAE #MedEd

585